A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer

Auris Nasus Larynx

Volumn 35, Issue 3, 2008, Pages 381-389

  Shimizu, Yoshinori ^a   Kondo, Satoru ^a   Shirai, Akiko ^a   Furukawa, Mitsuru ^a   Yoshizaki, Tomokazu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Immunohistochemistry; Interleukin 8; Matrix metalloproteinase 1; Oral cancer; Single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 8; INTERSTITIAL COLLAGENASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALIDITY; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TONGUE CANCER; TUMOR GROWTH;

AGED; ALLELES; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-8; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROMOTER REGIONS, GENETIC; TONGUE; TONGUE NEOPLASMS;

EID: 47549085398     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2007.12.002     Document Type: Article

References (35)

1. Brinckerhoff C.E., Rutter J.L., and Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res 6 (2000) 4823-4830
2. Basset P., Okada A., Chenard M.P., Kannan R., Stoll I., Anglard P., et al. Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications. Matrix Biol 15 (1997) 535-541
3. Nelson A.R., Fingleton B., Rothenberg M.L., and Matrisian L.M. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18 (2000) 1135-1149
4. Stetler-Stevenson W.G. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest 103 (1999) 1237-1241
5. Rigel D.S., Friedman R.J., Kopf A.W., and Silverman M.K. Factors influencing survival in melanoma. Dermatol Clin 9 (1991) 631-642
6. Murray G.I., Duncan M.E., O'Neil P., Melvin W.T., and Fothergill J.E. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 2 (1996) 461-462
7. Murray G.I., Duncan M.E., O'Neil P., McKay J.A., Melvin W.T., and Fothergill J.E. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol 185 (1998) 256-261
8. Ito T., Ito M., Shiozawa J., Naito S., Kanematsu T., and Sekine I. Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor. Mod Pathol 12 (1999) 669-674
9. Rutter J.L., Mitchell T.I., Butticè G., Meyers J., Gusella J.F., Ozelius L.J., et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58 (1998) 5321-5325
10. Zhu Y., Spitz M.R., Lei L., Mills G.B., and Wu X. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 61 (2001) 7825-7829
11. Kanamori Y., Matsushima M., Minaguchi T., Kobayashi K., Sagae S., Kudo R., et al. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 59 (1999) 4225-4227
12. Ghilardi G., Biondi M.L., Mangoni J., Leviti S., DeMonti M., Guagnellini E., et al. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 7 (2001) 2344-2346
13. Hashimoto T., Uchida K., Okayama N., Imate Y., Suehiro Y., Hamanaka Y., et al. Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma. Cancer Lett 211 (2004) 19-24
14. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324 (1991) 1-8
15. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
16. Ugurel S., Rappl G., Tilgen W., and Reinhold U. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J Clin Oncol 19 (2001) 577-583
17. Ren Y., Poon R.T., Tsui H.T., Chen W.H., Li Z., Lau C., et al. Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis. Clin Cancer Res 9 (2003) 5996-6001
18. Kassim S.K., El-Salahy E.M., Fayed S.T., Helal S.A., Helal T., Azzam E.-D., et al. Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients. Clin Biochem 37 (2004) 363-369
19. Benoy I.H., Salgado R., Van Dam P., Geboers K., Van Marck E., Scharpé S., et al. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin Cancer Res 10 (2004) 7157-7162
20. Bidwell J., Keen L., Gallagher G., Kimberly R., Huizinga T., McDermott M.F., et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun 2 (2001) 61-70
21. Hull J., Thomson A., and Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 55 (2000) 1023-1027
22. McCarron S.L., Edwards S., Evans P.R., Gibbs R., Dearnaley D.P., Dowe A., et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 62 (2002) 3369-3372
23. In: Sobin L.H., and Wittekind C. (Eds). TNM classification of malignant tumors. 5th ed. (1997), Wiley-Liss, New York, NY 4-8
24. Wickham C.L., Boyce M., Joyner M.V., Sarsfield P., Wilkins B.S., Jones D.B., et al. Amplification of PCR products in excess of 600 base pairs using DNA extracted from decalcified, paraffin wax embedded bone marrow trephine biopsies. Mol Pathol 53 (2000) 19-23
25. Wittwer C.T., Ririe K.M., Andrew R.V., David D.A., Gundry R.A., and Balis U.J. The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 22 (1997) 176-181
26. Nojiri T., Morita H., Imai Y., Maemura K., Ohno M., Ogasawara K., et al. Genetic variations of matrix metalloproteinase-1 and -3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese. Int J Cardiol 92 (2003) 181-186
27. Yoshizaki T., Sato H., Maruyama Y., Murono S., Furukawa M., Park C.S., et al. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer 79 (1997) 139-144
28. Kondo S., Wakisaka N., Schell M.J., Horikawa T., Sheen T.S., Sato H., et al. Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma. Int J Cancer 115 (2005) 368-376
29. Eisma R.J., Spiro J.D., and Kreutzer D.L. Role of angiogenic factors: coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma. Laryngoscope 109 (1999) 687-693
30. Holmes W.E., Lee J., Kuang W.J., Rice G.C., and Wood W.I. Structure and functional expression of a human interleukin-8 receptor. Science 253 (1991) 1278-1280
31. Richards B.L., Eisma R.J., Spiro J.D., Lindquist R.L., and Kreutzer D.L. Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma. Am J Surg 174 (1997) 507-512
32. Horikawa T., Kaizaki Y., Kato H., Furukawa M., and Yoshizaki T. Expression of interleukin-8 receptor A predicts poor outcome in patients with nasopharyngeal carcinoma. Laryngoscope 115 (2005) 62-67
33. Yuan A., Yang P.C., Yu C.J., Chen W.J., Lin F.Y., Kuo S.H., et al. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer. Am J Respir Crit Care Med 162 (2000) 1957-1963
34. Kido S., Kitadai Y., Hattori N., Haruma K., Kido T., Ohta M., et al. Interleukin 8 and vascular endothelial growth factor-prognostic factors in human gastric carcinomas?. Eur J Cancer 37 (2001) 1482-1487
35. Konno H., Ohta M., Baba M., Suzuki S., and Nakamura S. The role of circulating IL-8 and VEGF protein in the progression of gastric cancer. Cancer Sci 94 (2003) 735-740